Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

NOAH issues statement to clarify vaccination guidelines
Vet vaccinating Pekingese
NOAH says it has received many queries from practitioners about discrepancies on canine vaccinations.

NOAH statement aims to clear up discrepancies about canine vaccination

The National Office of Animal Health (NOAH) has issued a statement for veterinary surgeons on canine vaccination.

It discusses apparent discrepancies between global vaccination guidelines and advice contained within vaccine Summary of Product Characteristics (SPCs) and data sheets in the UK.

Following a recent publication from The World Small Animal Veterinary Association (WSAVA), entitled Vaccination Guidelines for New Puppy Owners, NOAH has received multiple queries from practitioners, seeking clarification regarding the messages it contains.

The statement clarifies that the publication is written from a global perspective. As many countries do not have the developed and educated companion animal market found in the UK, the available vaccines and their constituents and licensed claims are not universal across the globe.

Donal Murphy, NOAH technical executive and veterinary surgeon, explains: "NOAH members have received queries from practitioners seeking clarification when guidance written from a global perspective appears to differ from specific manufacturers' instructions, as set out in vaccine SPCs and data sheets in the UK.

"While there are some differences, we believe the profession within the UK has adopted many of the principles of the WSAVA guidance for some considerable time, such as annual health checks and determining individual requirements  in consultation with the owner."

NOAH welcomes any guidance assisting the veterinary profession in their determination of vaccine protocols, and helping to educate the public. Clarification is required on the routine use of non-core vaccines (particularly leptospirosis and kennel cough) and the role of serology testing to determine vaccination requirements and vaccine safety.

Mr Murphy says: "In the light of increased movement of pets from mainland Europe and beyond, the continued wide distribution of canine parvovirus and indeed the re-emergence of confirmed cases of canine distemper in a number of locations in the UK, the threat of infectious diseases to our pets is ever present and demands that a high level of vaccinal immunity is maintained across the country.

"It would be unfortunate if in seeking to provide 'best practice' advice on the use of vaccines, expert guidance was to lose sight of the need to maintain the confidence of both the pet owning public and indeed the veterinary profession itself in the continued value of the use of vaccines to keep significant infectious disease threats at bay."

NOAH believes the comment by the Veterinary Medicines Dictorate (VMD), responsible for the authorisation of veterinary medicines in the UK, sums up the value of vaccination to the health of our pets: '…the benefits of vaccination are considered significantly greater than the risks of infection by the ever present canine infectious diseases in the UK.'

Click here to view the statement.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.